Healthcare - Biotechnology - NASDAQ - US
$ 2.36
-19.7 %
$ 81.5 M
Market Cap
-2.38
P/E
BALANCE SHEET
27.9 M
ASSETS
8.42 M
LIABILITIES
19.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Genelux Corporation
| Current Assets | 24.2 M |
| Cash & Short-Term Investments | 23.2 M |
| Receivables | 0 |
| Other Current Assets | 1.01 M |
| Non-Current Assets | 3.69 M |
| Long-Term Investments | 0 |
| PP&E | 3.6 M |
| Other Non-Current Assets | 92 K |
| Current Liabilities | 6.55 M |
| Accounts Payable | 3.78 M |
| Short-Term Debt | 1.31 M |
| Other Current Liabilities | 1.46 M |
| Non-Current Liabilities | 1.87 M |
| Long-Term Debt | 1.87 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 9.4 | 0.4 | 4.5 | 11.3 | 0.4 |
| Short Term Investments | 13.8 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.0 | 1.5 | 1.3 | 0.1 | 0.1 |
| Total Current Assets | 24.2 | 1.9 | 5.8 | 11.5 | 0.6 |
| PP&E | 3.6 | 2.0 | 2.2 | 2.5 | 2.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 92 K | 1.7 | 92 K | 80 K | 80 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 27.9 | 5.5 | 8.1 | 14.0 | 3.3 |
| LIABILITIES | |||||
| Accounts Payable | 3.8 | 6.8 | 4.5 | 3.7 | 0 |
| Short Term Debt | 1.3 | 16.9 | 6.6 | 3.9 | 4.6 |
| Other Current Liabilities | 1.5 | 7.8 | 7.0 | 6.9 | 10.1 |
| Total Current Liabilities | 6.6 | 31.6 | 22.5 | 14.5 | 14.7 |
| Long Term Debt | 1.9 | 9.7 | 18.8 | 22.2 | 13.4 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 1 |
| Total Liabilities | 8.4 | 41.3 | 41.2 | 36.7 | 28.1 |
| EQUITY | |||||
| Common Stock | 27 K | 9 K | 9 K | 9 K | 24 K |
| Retained Earnings | (221.5) | (189.8) | (184.6) | (168.2) | (154.6) |
| Other Accumulative Comprehensive Income/Loss | 14 K | 2 K | 2 K | 2 K | 2 K |
| Total Equity | 19.5 | (35.8) | (33.1) | (22.7) | (24.8) |
| Total Liabilities and Equity | 27.9 | 5.5 | 8.1 | 14.0 | 3.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 24.4 | 24.6 | 23.6 | 23.6 | 23.6 |